LSM3
Basic information
Region (hg38): 3:14178817-14201122
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the LSM3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 7 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 2 | |||||
Total | 0 | 0 | 7 | 1 | 2 |
Variants in LSM3
This is a list of pathogenic ClinVar variants found in the LSM3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-14178880-A-T | not specified | Uncertain significance (Apr 20, 2023) | ||
3-14178939-C-T | Benign/Likely benign (Oct 28, 2024) | |||
3-14179017-C-G | Benign (Feb 11, 2019) | |||
3-14181574-C-T | Benign (Mar 29, 2018) | |||
3-14181599-A-T | not specified | Uncertain significance (May 23, 2024) | ||
3-14183960-G-A | not specified | Uncertain significance (Aug 19, 2024) | ||
3-14198066-G-C | not specified | Uncertain significance (Jun 28, 2023) | ||
3-14198069-C-T | not specified | Uncertain significance (Oct 16, 2024) | ||
3-14198076-A-T | not specified | Uncertain significance (Feb 19, 2025) | ||
3-14198109-T-C | not specified | Uncertain significance (Oct 05, 2022) | ||
3-14198111-G-A | not specified | Uncertain significance (Nov 25, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
LSM3 | protein_coding | protein_coding | ENST00000306024 | 4 | 22762 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000395 | 0.221 | 125711 | 0 | 36 | 125747 | 0.000143 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.397 | 50 | 58.6 | 0.854 | 0.00000316 | 657 |
Missense in Polyphen | 9 | 11.973 | 0.75168 | 172 | ||
Synonymous | 0.0385 | 21 | 21.2 | 0.989 | 0.00000108 | 198 |
Loss of Function | -0.136 | 8 | 7.59 | 1.05 | 5.57e-7 | 72 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000244 | 0.000242 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.0000464 | 0.0000462 |
European (Non-Finnish) | 0.000221 | 0.000220 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Plays role in pre-mRNA splicing as component of the U4/U6-U5 tri-snRNP complex that is involved in spliceosome assembly, and as component of the precatalytic spliceosome (spliceosome B complex) (PubMed:28781166). The heptameric LSM2-8 complex binds specifically to the 3'-terminal U-tract of U6 snRNA (PubMed:10523320). {ECO:0000269|PubMed:10523320, ECO:0000269|PubMed:28781166}.;
- Pathway
- RNA degradation - Homo sapiens (human);Spliceosome - Homo sapiens (human);Metabolism of RNA;mRNA Splicing - Major Pathway;mRNA decay by 5, to 3, exoribonuclease;Deadenylation-dependent mRNA decay;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA
(Consensus)
Recessive Scores
- pRec
- 0.156
Intolerance Scores
- loftool
- 0.673
- rvis_EVS
- -0.16
- rvis_percentile_EVS
- 41.25
Haploinsufficiency Scores
- pHI
- 0.140
- hipred
- Y
- hipred_score
- 0.769
- ghis
- 0.691
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.990
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Lsm3
- Phenotype
- immune system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- mRNA splicing, via spliceosome;mRNA processing;cytoplasmic mRNA processing body assembly;exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay
- Cellular component
- P-body;nucleus;nucleoplasm;U6 snRNP;cytosol;U4/U6 x U5 tri-snRNP complex;U2-type precatalytic spliceosome;catalytic step 2 spliceosome;Lsm2-8 complex;Lsm1-7-Pat1 complex
- Molecular function
- RNA binding;protein binding